8,995
Total Claims
$993K
Drug Cost
801
Beneficiaries
$1,239
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-91%
Opioid rate vs peers
0.2% vs 2.2% avg
-12%
Cost per patient vs peers
$1,239 vs $1,411 avg
-8%
Brand preference vs peers
9.8% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
18
Opioid Claims
$113
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
90% generic
Brand: 873 claims · $813K
Generic: 8,041 claims · $174K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 240 | $289K |
| Apixaban | 56 | $83K |
| Sitagliptin Phosphate | 46 | $61K |
| Lipase/Protease/Amylase | 17 | $31K |
| Insulin Aspart | 28 | $31K |
| Semaglutide | 13 | $27K |
| Cyclosporine | 20 | $25K |
| Sitagliptin Phos/Metformin Hcl | 16 | $25K |
| Atorvastatin Calcium | 969 | $17K |
| Insulin Lispro | 27 | $16K |
| Rivaroxaban | 15 | $16K |
| Insulin Detemir | 16 | $16K |
| Canagliflozin | 13 | $15K |
| Linagliptin | 12 | $14K |
| Fluticasone Propion/Salmeterol | 21 | $14K |
Prescribing Profile
Patient Profile
75
Avg Age
51%
Female
0.82
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data